Mycobacterium avium complex infection epidemiology and demographics: Difference between revisions
| Line 9: | Line 9: | ||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. [[Incidence]] is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with [[nucleoside reverse transcriptase inhibitors]] and [[protease inhibitors]], as well as antimycobacterial prophylaxis. | Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. [[Incidence]] is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with [[nucleoside reverse transcriptase inhibitors]] and [[protease inhibitors]], as well as antimycobacterial prophylaxis. Incidence is decreasing because of changes in treatment for HIV-infected patients; however, antimicrobial resistance may be increasing. | ||
==References== | ==References== | ||
Revision as of 14:28, 1 October 2012
|
Mycobacterium avium complex infection Microchapters |
|
Differentiating Mycobacterium avium complex infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mycobacterium avium complex infection epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mycobacterium avium complex infection epidemiology and demographics |
|
FDA on Mycobacterium avium complex infection epidemiology and demographics |
|
CDC on Mycobacterium avium complex infection epidemiology and demographics |
|
Mycobacterium avium complex infection epidemiology and demographics in the news |
|
Blogs on Mycobacterium avium complex infection epidemiology and demographics |
|
Directions to Hospitals Treating Mycobacterium avium complex infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Epidemiology and Demographics
Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. Incidence is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with nucleoside reverse transcriptase inhibitors and protease inhibitors, as well as antimycobacterial prophylaxis. Incidence is decreasing because of changes in treatment for HIV-infected patients; however, antimicrobial resistance may be increasing.